Sarepta Therapeutics Announces Second Quarter 2022 Financial Results and Recent Corporate Developments

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/23/2026

1. SPCX
2. NVDA
3. ACN
4. USO
5. GOOGL
6. APGE
7. HOOD
8. DFTX
9. MU
10. IBM

Go back to Sarepta Therapeutics Announces Second Quarter 2022 Financial Results and Recent Corporate Developments

Sarepta Therapeutics (SRPT) Misses Q2 EPS by 7c, Offers Guidance

August 2, 2022 4:36 PM EDT

Sarepta Therapeutics (NASDAQ: SRPT) reported Q2 EPS of ($1.18), $0.07 worse than the analyst estimate of ($1.11). Revenue for the quarter came in at $233.5 million versus the consensus estimate of $220.81 million.

GUIDANCE:

Sarepta Therapeutics sees FY2022 revenue of $905-920 million, versus the consensus of... More